Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
397.15
319.30
268.10
201.21
139.81
175.95
169.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
397.15
319.30
268.10
201.21
139.81
175.95
169.40
Raw Material Cost
260.66
216.36
178.28
140.36
110.57
128.23
112.35
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
78.32
63.78
53.26
38.51
32.17
35.63
33.77
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.44
8.30
8.04
7.21
6.96
8.59
3.62
Selling and Distribution Expenses
57.44
36.36
33.44
20.77
13.83
20.55
37.79
Other Expenses
-91.76
-72.08
-61.30
-45.72
-39.13
-44.22
-37.39
Total Expenditure (Excl Depreciation)
318.10
252.72
211.72
161.12
124.40
148.79
150.13
Operating Profit (PBDIT) excl Other Income
79.05
66.58
56.38
40.09
15.41
27.17
19.26
Other Income
5.09
2.37
0.77
0.97
0.44
1.40
1.98
Operating Profit (PBDIT)
123.59
95.44
77.38
59.92
31.79
49.35
31.95
Interest
13.44
8.30
8.04
7.21
6.96
8.59
3.62
Exceptional Items
0.00
1.72
0.24
0.00
0.00
0.42
0.00
Gross Profit (PBDT)
136.49
102.94
89.82
60.86
29.24
47.72
57.05
Depreciation
39.45
26.61
20.18
20.39
19.10
21.24
10.91
Profit Before Tax
70.70
62.25
49.40
32.31
5.73
19.94
17.43
Tax
16.05
15.89
12.48
8.21
7.17
6.26
5.51
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
54.65
46.36
36.92
24.10
-1.44
13.68
11.92
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
54.65
46.36
36.92
24.10
-1.44
13.68
11.92
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
54.65
46.36
36.92
24.10
-1.44
13.68
11.92
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
209.61
157.15
113.34
78.17
54.66
56.10
45.59
Earnings per share (EPS)
123.59
98.64
78.55
51.29
-3.06
29.11
25.35
Diluted Earnings per share
123.59
98.64
78.55
51.29
-3.06
29.11
25.35
Operating Profit Margin (Excl OI)
19.9%
20.81%
21.05%
19.16%
8.77%
15.18%
11.25%
Gross Profit Margin
27.74%
27.83%
25.95%
26.19%
17.76%
23.4%
16.73%
PAT Margin
13.76%
14.52%
13.77%
11.98%
-1.03%
7.78%
7.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 24.38% vs 19.10% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 17.88% vs 25.57% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 27.32% vs 21.49% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 61.93% vs 3.23% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has fallen from Mar 2024
Compare Annual Results Of Dr Agarwal's Eye With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
397.15
936.47
-539.32
-57.59%
Other Operating Income
0.00
0.00
0.00
Total Operating income
397.15
936.47
-539.32
-57.59%
Raw Material Cost
260.66
782.88
-522.22
-66.70%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
78.32
148.37
-70.05
-47.21%
Power Cost
0
0
0.00
Manufacturing Expenses
13.44
31.94
-18.50
-57.92%
Selling and Distribution Expenses
57.44
39.47
17.97
45.53%
Other Expenses
-91.76
-177.05
85.29
48.17%
Total Expenditure (Excl Depreciation)
318.10
825.62
-507.52
-61.47%
Operating Profit (PBDIT) excl Other Income
79.05
110.85
-31.80
-28.69%
Other Income
5.09
28.08
-22.99
-81.87%
Operating Profit (PBDIT)
123.59
183.25
-59.66
-32.56%
Interest
13.44
31.94
-18.50
-57.92%
Exceptional Items
0.00
1.53
-1.53
-100.00%
Gross Profit (PBDT)
136.49
153.59
-17.10
-11.13%
Depreciation
39.45
45.16
-5.71
-12.64%
Profit Before Tax
70.70
107.67
-36.97
-34.34%
Tax
16.05
25.49
-9.44
-37.03%
Provisions and contingencies
0
0
0.00
Profit After Tax
54.65
82.63
-27.98
-33.86%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
54.65
82.63
-27.98
-33.86%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
-0.45
0.45
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
54.65
82.18
-27.53
-33.50%
Equity Capital
0
0
0.00
Face Value
10.00
1.00
0.00
Reserves
209.61
837.68
-628.07
-74.98%
Earnings per share (EPS)
123.59
5.31
118.28
2,227.50%
Diluted Earnings per share
123.59
5.31
118.28
2,227.50%
Operating Profit Margin (Excl OI)
19.90%
11.75%
0.00
8.15%
Gross Profit Margin
27.74%
16.32%
0.00
11.42%
PAT Margin
13.76%
8.82%
0.00
4.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 397.15 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 24.38% vs 19.10% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 54.65 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.88% vs 25.57% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 118.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 27.32% vs 21.49% in Mar 2024
Annual - Interest
Interest 13.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 61.93% vs 3.23% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.90%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has fallen from Mar 2024






